GGrantIndex
← Search

DEVELOPMENT OF NOVEL DRUGS FOR HIGH RISK TRIPLE NEGATIVE BREAST CANCER TREATMENT

$524,234FY2015Department of the ArmyDOD

Regents Of The University Of Minnesota

Investigators

View source on USAspending →
DEVELOPMENT OF NOVEL DRUGS FOR HIGH RISK TRIPLE NEGATIVE BREAST CANCER TREATMENT · GrantIndex